Even in closely spaced pregnancies, Tdap vaccination is safe.
Individuals who receive tetanus-containing vaccines more than once every 5 years may experience increased local reactions. Because Tdap (tetanus, diphtheria, and acellular pertussis) vaccine is recommended for women during each pregnancy, those with short interbirth intervals may receive it just a few years after prior immunization. Using data from seven Vaccine Safety Datalink sites (29,155 pregnancies), researchers assessed acute adverse events in mothers and adverse birth outcomes in neonates according to the interval between Tdap and a prior tetanus-containing vaccine.
Local reactions, fever, preterm delivery, and small-for-gestational-age birth occurred no more frequently among women who received Tdap after intervals <2 years, or 2 to 5…
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)